Kodiak Sciences Inc KOD Total debt

Total debt at other companies

Regeneron PharmaceuticalsREGN

$2.71B+0.1%

EyePoint, Inc.EYPT

$22.37M-5.7%

KLR

Kalaris TherapeuticsKLRS

$1.41M—

4D Molecular TherapeuticsFDMT

$20.54M-13.9%

HRO

HarrowHROW

$308.58M-32.9%

PVL

Palvella TherapeuticsPVLA

$584K—

FAQ

What is Kodiak Sciences Inc's total debt?

Kodiak Sciences Inc (KOD) reported total debt of $55.99M in Q1 2026.

How has Kodiak Sciences Inc's total debt changed year-over-year?

Kodiak Sciences Inc's total debt decreased by 17.2% year-over-year, from $67.64M to $55.99M.

What is the long-term trend for Kodiak Sciences Inc's total debt?

Over 5 years (2020 to 2025), Kodiak Sciences Inc's total debt has grown at a -5.2% compound annual growth rate (CAGR), from $77.4M to $59.18M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.